- Hong Kong
- /
- Personal Products
- /
- SEHK:157
Natural Beauty Bio-Technology Full Year 2023 Earnings: HK$0.007 loss per share (vs HK$0.015 loss in FY 2022)
Natural Beauty Bio-Technology (HKG:157) Full Year 2023 Results
Key Financial Results
- Revenue: HK$336.0m (flat on FY 2022).
- Net loss: HK$15.1m (loss narrowed by 50% from FY 2022).
- HK$0.007 loss per share (improved from HK$0.015 loss in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Natural Beauty Bio-Technology's share price is broadly unchanged from a week ago.
Risk Analysis
We should say that we've discovered 1 warning sign for Natural Beauty Bio-Technology that you should be aware of before investing here.
Valuation is complex, but we're here to simplify it.
Discover if Natural Beauty Bio-Technology might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:157
Natural Beauty Bio-Technology
An investment holding company, offers skin care products and services in Mainland China, Taiwan, and internationally.
Mediocre balance sheet minimal.